Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
6000 participants
OBSERVATIONAL
2017-06-06
2030-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Currently, 4344 patients from 10 clinics and hospitals in Switzerland (Aarau, Basel, Bern, Chur, Horgen, Lausanne, Luzern, St. Gallen, Worb, Zurich) have been enrolled.
SPAC provides real-life data on children visiting the Swiss health care system for common respiratory problems. It will provide a research platform for health services research, and for nested clinical and transitional studies.
Publications and plain language summaries are listed on the study website: https://www.spac-study.ch/publikationen/
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Inhaled Corticosteroids in Preschool Children With Acute Dyspnea and Wheeze
NCT00962299
Early Environmental and Maternal Determinants of Airway Inflammation in Wheezing Disorders in Infants
NCT04286464
Comparing the Efficacy of Two Valved Holding Chambers in Acute Wheezing
NCT03900494
Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3% Inhalations
NCT01812525
Structured Light Plethysmography in Obstructive Airways Disease
NCT03499938
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Many studies have investigated the epidemiology of asthma in childhood, but most were based on data from the general population gathered either in cross-sectional or longitudinal surveys in schoolchildren.
Objectives:
The Swiss Paediatric Airway Cohort (SPAC) was set up in 2017 as a large, longitudinal database that is representative of children and adolescents visiting physicians in Switzerland for recurrent wheeze, cough, and exercise- or sleep-related respiratory symptoms. It will constitute a national research platform for studying healthcare provision, phenotypes and prognosis of these problems, and a sampling frame for conducting nested studies.
Methods:
Recruitment and participation:
The SPAC study recruits patients aged 0-16 that are referred to a paediatric outpatient clinic for recurrent respiratory symptoms. Families receive a SPAC information package containing an invitation letter, study information leaflet, informed consent form, and questionnaire. Physicians introduce the study to them, answer questions, and collect informed consent forms. Completed questionnaires are brought by families to the clinics or sent directly by families to the SPAC study centre using a prepaid return envelope. Eligible patients have consultations in participating clinics regardless of their study participation. No tests are performed specifically for SPAC; examinations and tests are done only if clinically indicated or ordered by the referring physician. Examinations such as lung function, allergy, blood, or bronchial challenge tests are done using respective standard procedures in the clinics. SPAC research team members visit participating centres at regular intervals to collect data. During the first year, caregivers or patients who are 14 years or older receive short online questionnaire through a link via email. One year after enrolment and each year thereafter, caregivers receive a follow-up questionnaire by post.
Information collected:
Questionnaires:
At baseline families complete a detailed questionnaire that includes sections on frequency, duration, severity, triggers, and history of upper and lower respiratory symptoms, and diagnoses, treatments, health behaviours, environmental factors, family history, and contact information. The monthly online questionnaires focus on symptoms, infections, and treatments which may change short-term. The yearly follow-up questionnaires focus on symptoms, treatments, and important risk factors during the past 12 months. Postal addresses for mailing are obtained from hospital records and updated by contacting community registration offices, a procedure used successfully for other registries and cohort studies in Switzerland. Questionnaires are currently available in German and French.
Medical records:
Information obtained from medical records includes reasons for referral; anthropometric measures; results from the physical examination and diagnostic tests including pulmonary function, allergy, and blood tests; information about asthma control; and final diagnoses and prescribed treatments.
Linkage to routine data:
For specific analyses, probabilistic record linkage will be used to merge data from SPAC with routine datasets collected by the Swiss Federal Statistical Office.
Study database:
The SPAC database is web-based, using the Research Electronic Data Capture (REDCap) platform developed at Vanderbilt University. REDCap is widely used in academic research and allows data entry and extraction in various formats.
Current status of the project:
SPAC recruits participants from 10 clinics in Switzerland including the children's hospital in Aarau, the University Children's hospital in Basel, the University Children's Hospital in Bern, the Children's hospital in Chur, a private paediatric pulmonology clinic in Horgen, the University Children's hospital in Lausanne, the Children's hospital in Luzern, the Children's hospital in St. Gallen, a private paediatric pulmonology clinic in Worb, and the University Children's Hospital in Zurich. By October 2023, 4344 children have agreed to participate in SPAC.
Publications and plain language summaries are listed on the study website: https://www.spac-study.ch/publikationen/
Funding:
Setting up SPAC was funded by the Swiss National Science Foundation (SNF32003B\_162820, SNF320030\_182628, SNF320030\_212519), and several local funding bodies including the Swiss Lung Association, the Lung League of St. Gallen, and the Allergiestiftung Ulrich Müller-Gierok.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient population
Children referred to paediatric pulmonary outpatient clinics for respiratory symptoms such as wheeze, cough, dyspnea, exercise- and sleep-related breathing problems.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Resident in Switzerland
* Seen in a paediatric pulmonary outpatient clinic due to respiratory problems
* Parents and patients above age 14 must be able to sign an informed consent form
Exclusion Criteria
0 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudia E Kuehni, Prof.
Role: STUDY_DIRECTOR
Institute of Social and Preventive Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vienna Open Medical Institute
Vienna, , Austria
Children's hospital Aarau
Aarau, , Switzerland
University Children's hospital Basel, UKBB
Basel, , Switzerland
Institute of Social and Preventive Medicine
Bern, , Switzerland
University Children's Hospital Bern, Inselspital
Bern, , Switzerland
Children's Hospital Chur
Chur, , Switzerland
Pulmonology clinic, Horgen
Horgen, , Switzerland
University Children's hospital Lausane, CHUV
Lausanne, , Switzerland
Children's hospital Lucerne
Lucerne, , Switzerland
Children's hospital St. Gallen
Sankt Gallen, , Switzerland
Pulmonology clinic, Worb
Worb, , Switzerland
University Children's Hospital Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Clemens Maedel
Role: primary
Dominik Müller-Suter
Role: primary
Anja Jochmann
Role: primary
Claudia E Kuehni, Prof
Role: primary
Philipp Latzin
Role: primary
Carmen Casaulta
Role: primary
Karin Hoyler
Role: primary
Sylvain Blanchon
Role: primary
Nicolas Regamey
Role: primary
Juerg Barben
Role: primary
Claudia Kuehni
Role: primary
Alexander Moeller
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Study website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPAC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.